Revisiting the AAPS Recommendations Paper on Validating LC-MS Bioanalytical Methods for Protein Therapeutics: 3 Years of Progress
Learn how the validation of LC-MS bioanalytical methods for protein therapeutics has changed over the last 3 years
This presentation revisits the AAPS recommendations paper on validating LC-MS bioanalytical methods for protein therapeutics. Find out how the application of LC-MS techniques to the bioanalysis of protein therapeutics in support of regulated studies has progressed over the last three years since the paper's original publication date.
You will also learn about future predictions and notable trends in drug development from discovery to clinical trials, such as the drive to understand and improve assay selectivity and specificity.
At Q2 Solutions, our scientists have extensive bioanalytical method development and liquid chromatography - tandem mass spectrometry expertise to not only meet your analytical needs, but to bring insights to the table that enhance the drug development process. Download the presentation to learn more.
Stephen Lowes, Ph.D., Senior Scientific Director, Bioanalysis and ADME Services